Lineage downgraded to Neutral from Overweight at JPMorgan

JPMorgan downgraded Lineage (LINE) to Neutral from Overweight with a price target of $75, down from $78. The firm made several rating changes in conjunction with its 2025 real estate investment trust and real estate services outlook. While Lineage shares are already down significantly since its July initial public offering, weakness in throughput volumes will likely continue to be a marginal headwind for its organic growth, the analyst tells investors in a research note. JPMorgan believes higher current equity costs may pull some of the company’s focus away from external growth and acquisitions at the margin.